secwatch / observer
8-K filed June 2, 2023, 7:59 PM ET ticker AWHL CIK 0000926617
leadership confidence high sentiment positive materiality 0.55

Aspira appoints director, new CFO; regains Nasdaq bid price compliance

Aspira Women's Health Inc.

item 5.02item 8.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Torsten Hombeck

Chief Financial Officer
AWHL · Aspira Women's Health Inc.
Effective
2023-06-15
Filed
June 2, 2023, 7:59 PM ET
As previously announced, Dr. Torsten Hombeck will begin his service as the Company’s Chief Financial Officer on June 15, 2023.
Departed (interim)

Marlene McLennan

Interim Chief Financial Officer
AWHL · Aspira Women's Health Inc.
Effective
2023-05-31
Successor
Dr. Torsten Hombeck
Filed
June 2, 2023, 7:59 PM ET
Effective May 31, 2023, Marlene McLennan’s term as Interim Chief Financial Officer of Aspira Women’s Health Inc. (the “Company”) has come to a close, pursuant to her Employment Agreement with the Company.
Appointed

Dr. Winfred Parnell

director
AWHL · Aspira Women's Health Inc.
Effective
2023-06-01
Filed
June 2, 2023, 7:59 PM ET
On June 1, 2023, the Company’s Board of Directors (the “Board”) appointed Dr. Winfred Parnell as a director, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Torsten Hombeck was appointed as Chief Financial Officer at Aspira Women's Health Inc..

Action
will begin his service
Role
Chief Financial Officer
Exact text from the filing
As previously announced, Dr. Torsten Hombeck will begin his service as the Company’s Chief Financial Officer on June 15, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Marlene McLennan departed as Interim Chief Financial Officer at Aspira Women's Health Inc..

Action
has come to a close
Role
Interim Chief Financial Officer
Exact text from the filing
Effective May 31, 2023, Marlene McLennan’s term as Interim Chief Financial Officer of Aspira Women’s Health Inc. (the “Company”) has come to a close, pursuant to her Employment Agreement with the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Winfred Parnell was appointed as director at Aspira Women's Health Inc..

Action
appointed
Role
director
Exact text from the filing
On June 1, 2023, the Company’s Board of Directors (the “Board”) appointed Dr. Winfred Parnell as a director, effective immediately.
View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR
accession 0000926617-23-000052
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.